The pharma industry’s reputation has continued to slide — and it’s mostly due to the persistent issue of high drug costs, according to a report released by research firm PatientView this week.

The NBA’s ratings discourse this season has arguably generated more headlines than the actual play on the court. That’s a bit of hyperbole, but the sentiment is true. This year, more than usual, the ...

Target faced significant sales and reputation declines after rolling back DEI policies and controversial Pride Month displays, leading to widespread boycotts and a 30% stock drop. However, RepTrak ...

Forbes contributors publish independent expert analyses and insights. Lindsay Kohler is a behavioral scientist and future of work expert. In a time when trust in business is declining — Edelman ...

The NBA’s ratings discourse this season has arguably generated more headlines than the actual play on the court. That’s a bit of hyperbole, but the sentiment is true. This year, more than usual, the ...